VREX Stock Analysis: Buy, Sell, or Hold?
VREX - Varex Imaging Corporation Common Stock
$10.35
-0.17 (-1.62%)
▼
5d:
-1.43%
30d:
+2.78%
90d:
-2.54%
BUY
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When VREX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VREX shows positive signals but monitor for confirmation. Market pricing in 6.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: VREX shows positive signals but monitor for confirmation. Market pricing in 6.4% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$25.07
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.57
33.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VREX is currently trading at $10.35, which is considered fair relative to its 30-day fair value range of $9.94 to $10.64. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.9) compared to its historical average (12.1). Remarkably, the market is currently pricing in an annual earnings decline of 6.4% over the next few years. This pessimistic expectation contrasts with the company's recent 453.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VREX is in a strong downtrend. The price is currently testing key support at $10.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.00 (+71.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VREX is in a strong downtrend. The price is currently testing key support at $10.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.00 (+71.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$9.94 -
$10.64
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.1% below Wall St target ($18.00)
Trading Range Analysis
30-Day Trading Range
$9.94 -
$10.64
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$10.08
Resistance Level
$11.65
Current Trend
Strong Downtrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.89
Wall Street Target
$18.00
(+71.1%)
Revenue Growth (YoY)
1.5%
Earnings Growth (YoY)
453.4%
Profit Margin
-9.6%
Valuation Discount vs History
-6.4% cheaper
PE vs Historical
9.9 vs 12.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.4%
(market-implied from PE analysis)
1-Year Target
$9.85
(-6%)
2-Year Target
$9.22
(-12%)
3-Year Target
$8.63
(-18%)
3-Yr Target (if PE normalizes)
(PE: 10→12)
$10.56
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 36.8%)
$59.28
(+464%)
Base:
(SPY PE: 9.9, Growth: 36.8%)
$26.91
(+156%)
Bear:
(PE: 8.4, Growth: 36.8%)
$22.87
(+117%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.9 to 12.1
Stabilization Target:
$12.87
(+22.4%)
PE Expansion Potential:
+22.4%
Share & Embed Analysis
Last updated: June 24, 2026 3:46 PM ET
Data refreshes hourly during market hours. Next update: 4:46 PM
Data refreshes hourly during market hours. Next update: 4:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VREX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jay K Kunkel
SELL
4510 shares
2026-03-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 67 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 65 BUY |
